Jin Z, Wu J, Wang Y, Huang T, et al. Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults. J Infect 2023 Oct 26:S0163-4453(23)00543-1. doi: 10.1016/j.jinf.2023.
PMID: 37898410